News & Events

August 19, 2021

FDA Clears Deep TMS System for Comorbid Anxiety Symptoms

Highlighting the FDA clearance announcement as a promising step in managing comorbid anxiety symptoms,...

August 18, 2021

FDA OKs Stimulation Device for Anxiety in Depression

Coverage of BrainsWay receiving FDA Clearance for the treatment of comorbid anxiety symptoms in adults...

August 18, 2021

BrainsWay clinches FDA nod for magnetic stimulation device to ease anxious depression

In-depth explanation as to how Deep TMS’s newest anxiety-depression clearance will help achieve BrainsWay’s...

August 16, 2021

Living with O.C.D. in a Pandemic

Highlights include treatment methods for OCD, emphasizing noninvasive techniques such as TMS as a valuable...

August 18, 2021

FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients

Expanded Depression Indication Further Demonstrates Company’s Leadership Position BURLINGTON, Mass....

August 17, 2021

BrainsWay Hosting Key Opinion Leader Webinar on its Deep TMS™ Therapy for Treating Mental Health Disorders

BURLINGTON, MA. and JERUSALEM, August 17, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

August 11, 2021

BrainsWay Reports Second Quarter 2021 Financial Results and Operational Highlights

Strong Revenue Growth of 45% Year-over-Year in Q2 2021 Gained Meaningful Traction in Reimbursement for...

July 30, 2021

Neurostimulation for Mental Health Disorders

Topics discussed in the interview include Christopher von Jako’s background; his inspiration as...

July 28, 2021

BrainsWay to Report Second Quarter 2021 Financial Results on August 11, 2021

CRESSKILL, N.J. and JERUSALEM, July 28, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

July 26, 2021

CW Focus Atlanta – Deep TMS™

Mental health advocate Buffie Purselle of Rejuvenate TMS recently appeared on CW’s Focus Atlanta,...

July 12, 2021

Active Recovery TMS: Treating obsessive-compulsive disorder

Dr. Prithan Raj, Chief Medical Officer (CMO) at Active Recovery TMS discusses how his clinic treats obsessive-compulsive...

July 9, 2021

Evaluating Transcranial Magnetic Stimulation Technologies: Deep vs. Traditional

Dr. Rodriguez discusses the differences between Deep TMS vs. Traditional TMS, highlighting how Deep TMS...

July 6, 2021

BrainsWay to Present at the Ladenburg Thalmann 2021 Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, July 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

June 11, 2021

Centene Goes “Sci-Fi” with new Brain Treatment

Highlights around the partnership between BrainsWay and Centene regarding Deep TMS™ coverage, with...

June 8, 2021

BrainsWay to Present at the Raymond James Human Health Innovation Conference

CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 7, 2021

BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate

CRESSKILL, N.J. and JERUSALEM, Israel, June 7, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

June 2, 2021

BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC

HCSC Covers Approximately 17 Million Members Across Five States CRESSKILL, N.J. and JERUSALEM, Israel,...

June 1, 2021

BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor

Palmetto GBA, Administrator of Medicare in Seven States, Publishes Draft Local Coverage Determination CRESSKILL,...